Navigation Links
Derma Sciences Gains FDA Clearance for Novel BIOGUARD(TM) Barrier Dressing with NIMBUS(R) Technology
Date:2/27/2009

Dressing Offers a Highly Effective and Affordable New Option to Help Combat the Escalating MRSA Crisis

PRINCETON, N.J., Feb. 27 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced today that its first BIOGUARD Barrier Dressings have received clearance from the U.S. Food and Drug Administration for marketing and distribution. BIOGUARD will offer surgeons, wound care clinicians, infection control experts and primary care doctors a new weapon against the transmission of such virulent bacteria as Methicillin-resistant Staphylococcus aureus (MRSA). Coming on the heels of Derma Sciences' successful launch of its MEDIHONEY(TM) dressing line in 2008, BIOGUARD is the company's latest new product entrant into the $14 billion global wound care market. Sales of the dressings are expected to commence in June, 2009.

Speaking about the FDA clearance, Derma Sciences' CEO Ed Quilty stated, "This clearance represents a significant milestone for Derma Sciences and provides another large step in implementing our strategic plan. We believe that BIOGUARD, a cost-effective gauze-based dressing that has been shown to kill 99.999% of MRSA, will be a great asset to healthcare providers as they look for more effective and efficient ways to combat the transmission of virulent pathogens throughout their facilities. Surgical site infections are a serious concern, and with changes in reimbursement, prevention has become a major objective for hospitals." Quilty continued, "This gives our sales reps yet another novel wound care product to sell, and will help Derma Sciences reach our goal of profitability in a quicker timeframe. BIOGUARD will open many new doors for us, especially on the gauze side of the business, a large component of the $14 billion global wound care market."


'/>"/>
SOURCE Derma Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Coria Laboratories Announces Acanya(TM) Gel Data Presentations at 67th American Academy of Dermatology Annual Meeting
2. Christian Diaz Joins Rodan + Fields(R) Dermatologists as Vice President of Sales
3. Galderma Launches New Cetaphil(R) SPF 50 Product
4. High and Super-High Potency Topical Corticosteroids Will Remain Decision Resources Clinical Gold Standard Through 2017 for the Treatment of Atopic Dermatitis
5. Skinvisible Signs Dermatology Agreement With RHEI Pharmaceuticals
6. Galderma Wins FDA Approval for Vectical(TM) Ointment, a Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis
7. Direct Selling Luminary, Robert M. Henry, Partners With Rodan + Fields(R) Dermatologists as Strategic Business Advisor
8. New Source of Information on Scleroderma Medications
9. Dr. Sherrell Aston Addresses the Popularity of Dermal Fillers and Possible Long Term Side Effects
10. Galderma Announces Availability of Epiduo(TM) Gel, the First and Only Combination Treatment with a Retinoid and Benzoyl Peroxide to Treat Acne
11. PriCara(R) Recalls 50 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Paul, MN (PRWEB) September 02, 2014 ... been refined and specially formulated, while preserving the foundation ... solutions for hair loss and scalp problems. There is ... on the market today. , Hair loss is a ... ages. Until now, options for treatment have been limited ...
(Date:9/2/2014)... YOUNGSTOWN, Ohio (PRWEB) September 02, 2014 Humility ... at Home, Sept. 18 at St. Elizabeth Health Center, 1044 ... that provides information about more than 200 common health problems ... family, preventing illness and injury, and advice on when to ... 11 a.m. to noon in the Youngstown Room; the evening ...
(Date:9/2/2014)... announce that the following papers will be published ... 2014, taking place in Barcelona, Spain, 30 August ... biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting ... single-blind, non-inferiority trial, Windecker et al , ... polymer, and drug release have improved clinical outcomes ...
(Date:9/2/2014)... Researchers in New Delhi, India have published a paper on ... asbestos-contaminated work clothes for just 3 months as a child. ... a new article. Click here to read it now. ... patient was diagnosed with mesothelioma after complaining of ... come in contact with her miner father’s dirty work clothes ...
(Date:9/2/2014)... Headaches, both chronic and acute ruin lives. They can ... friends, sleeping and just coping well with daily activities. ... worldwide. The medications prescribed for these conditions frequently don’t ... cases of headache and back pain are of a mechanical ... detect and fix the cause. , When a sports ...
Breaking Medicine News(10 mins):Health News:New All Natural, Organic Hair Recovery Products by Moroccan Eco-Biologics, Restore Lost Hair with No Side Effects 2Health News:HMHP Offers ‘Health at Home’ Workshop 2Health News:The Lancet: European Society of Cardiology Congress 2014 media alert 2Health News:New Report Illustrates That Even Brief Asbestos Exposure Can Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:Physical Therapists in Houston Learn Pain Relief Techniques 2
... 13 Ruth W. Messinger, president of American ... today calling on the international community to actively ... into Darfur so workers can continue providing critical ... displaced persons throughout Darfur and Chad."The already fragile ...
... earning the doctor of optometry degree are encouraged to attend the ... and the N.C. State Education Assistance Authority. Conferences are scheduled ... East ... 10:00 a.m. - 12:00 noon, Tuesday, March 24, 2009 in the ...
... 20th Annual AIDS Walk Houston for Living Positive By DesignHOUSTON, ... series "Project Runway," is visiting Houston for the 20th Annual ... his national HIV and AIDS education initiative. On Sunday, ... helps to support more than 100,000 people with HIV and ...
... million gift for its campaign to build a children,s, ... Mission Bay campus, near downtown San Francisco. This is ... hospital fundraising campaign and among the largest gifts in ... percent match to encourage support from other philanthropists, was ...
... Clinical Care Options (CCO), a leader in education ... information provider, have been named the official providers of ... AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention ... 2009, and the XVIII International AIDS Conference in Vienna, ...
... shift to web news -LITTLE FALLS, N.J., March 13 ... reports on the closing and downsizing of many U.S. ... its list of 10 major daily papers most likely to fold ... New York Times reports that three papers ...
Cached Medicine News:Health News:Optometry Career Conferences Set for Five N.C. Campuses in March 2Health News:'Project Runway' Designer in Houston to Educate About Living With HIV and Combat Stigma Associated With the Disease 2Health News:'Project Runway' Designer in Houston to Educate About Living With HIV and Combat Stigma Associated With the Disease 3Health News:UCSF Medical Center receives $125 million gift to build new hospital 2Health News:UCSF Medical Center receives $125 million gift to build new hospital 3Health News:UCSF Medical Center receives $125 million gift to build new hospital 4Health News:Clinical Care Options and NAM Selected by the International AIDS Society to Collaborate on Official Online Conference Coverage From Annual Meetings 2Health News:Clinical Care Options and NAM Selected by the International AIDS Society to Collaborate on Official Online Conference Coverage From Annual Meetings 3Health News:Print Media Under Siege - Are Readers Disappearing? 2
(Date:9/2/2014)... 2014  Boston Scientific Corporation (NYSE: ... to purchase the Interventional business of Bayer AG. ... to offer physicians and healthcare systems a more ... conditions. The addition of the Bayer ... the Boston Scientific strategy to provide a comprehensive ...
(Date:9/2/2014)... , Sept. 2, 2014  Based on its ... device market, Frost & Sullivan recognizes Novian Health, ... Sullivan Award for Technology Innovation Leadership. Novian Health ... and malignant tumors with its proprietary technology, Novilase ... a reliable, accurate, and easy-to-control ultrasound-guided thermo ablation ...
(Date:9/2/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... consumables to the medical, research and veterinary markets, announced ... Executive Officer, will present at the Morgan Stanley Global ... a.m. ET. The conference will be held at the ... City . About Abaxis Abaxis develops, ...
Breaking Medicine Technology:Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 2Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 3Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 4Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 5Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 2Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 3Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 4Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 5Abaxis, Inc. to Present at the Morgan Stanley Global Healthcare Conference 2
... 1 Clinicians at Institut Catala d,Oncologia (ICO) in Barcelona ... RapidArc® radiotherapy from Varian Medical Systems (NYSE: VAR). A 73-year-old prostate cancer ... country to receive the fast and efficient treatment. , ... "The treatment went very well and the patient ...
... SAN DIEGO , June 1, 2010 Amylin Pharmaceuticals, ... , MD has been appointed Senior Vice President, Research and Development. ... Chief Medical Officer. These leadership changes will strengthen the Company,s focus ... its late-stage development programs, both important value drivers for the Company. ...
Cached Medicine Technology:Prostate Cancer Patient First in Spain to Receive Fast and Precise RapidArc(R) Radiotherapy Treatment from Varian 2Prostate Cancer Patient First in Spain to Receive Fast and Precise RapidArc(R) Radiotherapy Treatment from Varian 3Prostate Cancer Patient First in Spain to Receive Fast and Precise RapidArc(R) Radiotherapy Treatment from Varian 4Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development 2Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development 3Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development 4Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development 5
Liquichek Whole Blood Volatiles Control is an assayed liquid control for monitoring volatile compounds. This product is available in 2 levels....
qUAntify Control is designed to monitor the performance of urine dipstick testing. The control is available in 12 mL ready-to-use dropper bottles....
Lyphochek Urine Bone Markers Control is a bilevel human urine based control designed to monitor tests for urinary markers of osteoporosis management and bone resorption....
Lyphochek Tumor Marker Control is a comprehensive, bilevel product designed to assess the performance of various cancer antigen tests, including esoteric tumor markers....
Medicine Products: